PER — Percheron Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- AU$67.62m
- AU$50.44m
- AU$0.38m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.9 | 4.06 | 6.02 | 19.2 | 11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.606 | 0.689 | 0.601 | 1.84 | 1.66 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.7 | 5.21 | 6.7 | 22.2 | 12.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.002 | 0.138 | 0.302 | 0.217 | 0.151 |
Total Assets | 3.7 | 5.35 | 7 | 22.4 | 12.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.88 | 0.799 | 1.05 | 1.16 | 2.81 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.889 | 0.821 | 1.27 | 1.3 | 2.87 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2.81 | 4.53 | 5.73 | 21.1 | 9.98 |
Total Liabilities & Shareholders' Equity | 3.7 | 5.35 | 7 | 22.4 | 12.8 |
Total Common Shares Outstanding |